Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Liabilities and Shareholders Equity: 2020-2025

Historic Liabilities and Shareholders Equity for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $85.2 million.

  • Journey Medical's Liabilities and Shareholders Equity rose 33.02% to $85.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $331.6 million, marking a year-over-year increase of 21.60%. This contributed to the annual value of $80.2 million for FY2024, which is 4.41% up from last year.
  • As of Q3 2025, Journey Medical's Liabilities and Shareholders Equity stood at $85.2 million, which was up 4.97% from $81.2 million recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Liabilities and Shareholders Equity registered a high of $120.9 million during Q1 2022, and its lowest value of $64.0 million during Q3 2024.
  • For the 3-year period, Journey Medical's Liabilities and Shareholders Equity averaged around $76.0 million, with its median value being $76.8 million (2023).
  • Per our database at Business Quant, Journey Medical's Liabilities and Shareholders Equity skyrocketed by 87.42% in 2021 and then slumped by 39.05% in 2023.
  • Quarterly analysis of 5 years shows Journey Medical's Liabilities and Shareholders Equity stood at $97.3 million in 2021, then rose by 8.10% to $105.2 million in 2022, then dropped by 26.92% to $76.8 million in 2023, then grew by 4.41% to $80.2 million in 2024, then surged by 33.02% to $85.2 million in 2025.
  • Its Liabilities and Shareholders Equity was $85.2 million in Q3 2025, compared to $81.2 million in Q2 2025 and $85.0 million in Q1 2025.